Skip to content

Role of Homoeopathy in Attention Deficit Hyperactivity Disorder

Therapeutic Response of Individualized Homoeopathic Medicine in the Management of Attention Deficit Hyperactivity Disorder- An Exploratory Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045422
Enrollment
66
Registered
2022-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F90- Attention-deficit hyperactivity disorders

Interventions

Intervention1: Group A - Homoeopathic Medicines: Homoeopathic Medicines Gloubles form Pill Size 30 Oral Route of administration centesimal scale Follow up every 4 weeks. Repetition of the dose accordi

Sponsors

Bakson Homoeopathic Medical Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects who fit the criteria of ADHD according to the diagnostic criteria given in DSM ââ?¬â?? V. 2. Age group 6 - 14 years will be taken for study 3. Sex: Both sexes are included.

Exclusion criteria

Exclusion criteria: 1. Subject with other psychiatric conditions like Down syndrome, Intellectual Disability etc. 2. Patients with a severe systemic illness like juvenile diabetes, suicidal tendency, child schizophrenia etc. 3. Children presenting with the concurrent convulsive disorder. 4. Children on psychotropic drugs: antidepressants, anti-anxiety medication, mood stabilizers, antipsychotics. 5. Children who are on Allopathic medicine for ADHD

Design outcomes

Primary

MeasureTime frame
Positive changes on NICHQ VANDERBILT ASSESSMENT SCALE is expectedTimepoint: Evaluation done at baseline, 4 weeks, 8 weeks till 6 months 12 Months study 5 months enrollment 6 months Follow up 1 month analysis

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Mansi Chawla

Bakson Homoeopathic Medical College & Hospital

dr.tarishimanjul@gmail.com8887515433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026